BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19268330)

  • 1. [Cryptococcus neoformans meningoencephalitis in a patient treated with rituximab].
    Sánchez-Ojanguren J; Isern-Segura I; Chico-Chumillas C; Javaloyas-de-Morlius M
    Med Clin (Barc); 2009 Jun; 133(4):157-8. PubMed ID: 19268330
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryptococcal meningitis in an HIV-negative patient with rheumatoid arthritis treated with rituximab.
    Wingfield T; Jani M; Krutikov M; Mayer J; Uriel A; Marks J; Ustianowski AP
    Rheumatology (Oxford); 2011 Sep; 50(9):1725-7. PubMed ID: 21700684
    [No Abstract]   [Full Text] [Related]  

  • 3. Cryptococcal meningitis in a patient treated with infliximab.
    Muñoz P; Giannella M; Valerio M; Soria T; Díaz F; Longo JL; Bouza E
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):443-6. PubMed ID: 17240111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
    Quartier P; Tournilhac O; Archimbaud C; Lazaro L; Chaleteix C; Millet P; Peigue-Lafeuille H; Blanche S; Fischer A; Casanova JL; Travade P; Tardieu M
    Clin Infect Dis; 2003 Feb; 36(3):e47-9. PubMed ID: 12539090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma.
    Servais S; Caers J; Warling O; Frusch N; Baron F; De Prijck B; Beguin Y
    Br J Haematol; 2010 Aug; 150(3):379-81. PubMed ID: 20408837
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab-induced hypersensitivity pneumonitis.
    Tonelli AR; Lottenberg R; Allan RW; Sriram PS
    Respiration; 2009; 78(2):225-9. PubMed ID: 18843175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab-induced acute pulmonary fibrosis.
    Leon RJ; Gonsalvo A; Salas R; Hidalgo NC
    Mayo Clin Proc; 2004 Jul; 79(7):949, 953. PubMed ID: 15244399
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid infusion of rituximab with or without steroid-containing chemotherapy: 1-yr experience in a single institution.
    Salar A; Casao D; Cervera M; Pedro C; Calafell M; Abella E; Alvarez-Larrán A; Besses C
    Eur J Haematol; 2006 Oct; 77(4):338-40. PubMed ID: 16856919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus meningoencephalitis after rituximab treatment for primary central nervous system lymphoma.
    Siakantaris MP; Argyropoulos KV; Ioannou S; Papadopoulou V; Tzeletas G; Tsonis J; Dimitrakopoulou A; Yiannopoulou KG; Pangalis GA; Vaiopoulos G
    Neurologist; 2015 Jan; 19(2):35-7. PubMed ID: 25607329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset neutropenia following rituximab.
    McLaughlin P
    Leuk Lymphoma; 2006 Jun; 47(6):965-6. PubMed ID: 16840184
    [No Abstract]   [Full Text] [Related]  

  • 11. Organizing pneumonia associated with rituximab: Challenges raised by establishing causality.
    Lioté H
    Joint Bone Spine; 2008 May; 75(3):260-2. PubMed ID: 18424160
    [No Abstract]   [Full Text] [Related]  

  • 12. Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy.
    Niscola P; Del Principe MI; Maurillo L; Venditti A; Buccisano F; Piccioni D; Amadori S; Del Poeta G
    Leukemia; 2005 Oct; 19(10):1840-1. PubMed ID: 16094417
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged remission in a patient with relapsed follicular lymphoma after a single course of rituximab.
    Jensen M; Elter T; Engert A; Reiser M
    Onkologie; 2006 Mar; 29(3):90-2. PubMed ID: 16514269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcus neoformans meningitis in the rat.
    Goldman DL; Casadevall A; Cho Y; Lee SC
    Lab Invest; 1996 Dec; 75(6):759-70. PubMed ID: 8973471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterovirus infection of neuronal cells post-Rituximab.
    Kiani-Alikhan S; Skoulidis F; Barroso A; Nuovo G; Ushiro-Lumb I; Breuer J; Lister A; Mattes F
    Br J Haematol; 2009 Aug; 146(3):333-5. PubMed ID: 19466969
    [No Abstract]   [Full Text] [Related]  

  • 16. New therapies, new concerns: rituximab-associated lung injury.
    Lands LC
    Pediatr Nephrol; 2010 Jun; 25(6):1001-3. PubMed ID: 20195643
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia.
    Stamatopoulos K; Papadaki T; Pontikoglou C; Athanasiadou I; Stavroyianni N; Bux J; Batsis I; Pyrovolaki K; Paterakis G; Anagnostou D; Anagnostopoulos A; Papadaki HA
    Leukemia; 2008 Jul; 22(7):1446-9. PubMed ID: 18185527
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment.
    Hellerstedt B; Ahmed A
    Ann Oncol; 2003 Dec; 14(12):1792. PubMed ID: 14630688
    [No Abstract]   [Full Text] [Related]  

  • 19. Cryptococcus neoformans meningitis in a patient with hairy cell leukemia.
    Dinçol G; Kahraman R
    Am J Hematol; 2006 May; 81(5):387. PubMed ID: 16628737
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostatic sequestration of Cryptococcus neoformans in immunocompromised persons treated for cryptococcal meningoencephalitis.
    Ndimbie OK; Dekker A; Martinez AJ; Dixon B
    Histol Histopathol; 1994 Oct; 9(4):643-8. PubMed ID: 7894136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.